Biotechnology News

March 28, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

March 28, 2014

TAINAN, Taiwan--(BUSINESS WIRE)--The partnership between National Cheng Kung University (NCKU), southern Taiwan, and Delta Electronics, the nation's biggest supplier of power supply units, has been hailed as the most successful industry-academia...

March 28, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): The Nomination Committee of Meda AB proposes the election of Guido Oelkers and Martin Svalstedt as new board members and proposes the appointment of Martin Svalstedt as...

March 28, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: On April 1, 2014, Precise Biometrics AB (STO:PREC) will publish a convening notice for the Annual General Meeting in Post- och Inrikes Tidningar and on the company’s web page. An advertisement that...

March 27, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is supporting the Annual Tour de Cure in Australia through its sponsorship, fund raising efforts, and donation of...

March 27, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Marketing Authorisation Application (MAA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the...

March 27, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna announce fourth quarter and full year 2013 financial results.

March 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that the U.S. Food and Drug Administration’s (FDA) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee determined by a unanimous vote...

March 27, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Bordetella pertussis (B. pertussis), its fifth assay on the...

March 27, 2014

WASHINGTON--(BUSINESS WIRE)--BIO, the NSF, and the NIH today announced an agreement to feature SBIR/STTR funded early-stage biotech companies in a newly-created Innovation Zone at the 2014 BIO International Convention.

March 27, 2014

SAN DIEGO--(BUSINESS WIRE)--Nature Genetics Founding Editor Kevin Davies Joins Pathway Genomics’ Scientific Advisory Board

March 27, 2014

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter has announced significant progress in its solution for state-of-the-art product packaging, designed to support the prevention of product counterfeiting. This innovative development is in response to...

March 27, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter and year ended December 31, 2013. Revenues for the year ended December 31, 2013 were $30.8 million compared to $21.6...

March 27, 2014

HOUSTON--(BUSINESS WIRE)--CompanionDx Reference Lab (www.companiondxlab.com), a high-complexity CLIA-certified laboratory specializing in pharmacogenomics, cancer...

March 27, 2014

WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) announced that Kay Holcombe will be joining staff as Senior Vice President, Science Policy. “We are very fortunate to have Kay join the BIO team,” said Jim...

March 27, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex confirms Takeda will present additional data from the Examine Trial at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

PARIS--(BUSINESS WIRE)--Privately held Arterial Remodeling Technologies (‘ART’) announced today that it has signed a structured buyout agreement with Terumo Corporation. Under the agreement, ART and Terumo Corporation will collaborate in the...

March 27, 2014

DENVER--(BUSINESS WIRE)--An outbreak of the deadly Ebola virus in West Africa has prompted Corgenix Medical to extend its existing Lassa viral hemorrhagic fever rapid test development to include the Ebola virus.

March 27, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the year ended December 31, 2013. “2013 was a productive and eventful year for Retrophin,” said Martin Shkreli, Founder and Chief Executive Officer...

March 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Hosted by the BioPharmaceutical Technology Center Institute (BTC Institute) and Promega Corporation, the 13th Annual International Bioethics Forum will take place May 1–2, 2014, in Madison, Wisconsin.

March 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Expanding on its mission to put patients at the center of clinical research, PatientsLikeMe says that patients can now apply to lead the development of new health outcome measures on its ORE platform

March 27, 2014

NEW YORK--(BUSINESS WIRE)--SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on NanoViricides, Inc. (NYSE-MKT:NNVC), a...

March 27, 2014

SAN ANTONIO--(BUSINESS WIRE)--Mobile healthcare leader achieves another first: mobilizing waveform data from non-invasive sensors operating outside hospital walls for high-risk pregnancies.

March 27, 2014

DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriTeQ rebrands its Q Inside SmartMarker radiation dose measurement product, which is FDA cleared to measure radiation dose at the site of a breast tumor or prostate tumor.

March 27, 2014

PRINCETON, N.J., & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the results of a pre-specified subanalysis of the Phase 3 ARISTOTLE trial that assessed the effect of blood...

March 27, 2014

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics Submits Request for Face to Face Meeting with FDA; Receives Notification on PMA Extension for LuViva® Advanced Cervical Scan

March 27, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Industry Expert from the European Medicines Agency (EMA) joins Quintiles

March 27, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--The Tech Council of Maryland (TCM), Maryland’s largest technology trade association for life science and technology, today announced that individuals from IBM, Sucampo Pharmaceuticals and the Universities at Shady...

March 27, 2014

EAGAN, Minn.--(BUSINESS WIRE)--Biothera will present data from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) at the European Society for Medical Oncology’s 2014 European Lung Cancer Conference on March 28 in Geneva,...

March 27, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the Phase 2b results of a 24 week, randomized, placebo-controlled, dose-ranging study of investigational bococizumab, the proposed generic name for RN316. Statin treated patients...

March 27, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5 million, including an upfront payment of $29.5 million, plus...

March 27, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. announces plans to create two separate, independent global healthcare companies -- one focused on innovative biopharmaceuticals and the other on life-saving medical products

March 27, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces resubmission of NDA for ILUVIEN for DME

March 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that the Nasdaq Stock Market has halted trading of the company’s stock.

March 27, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--David Green, CEO of Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), was interviewed on Bloomberg TV’s “Market Makers” program on March 26.

March 27, 2014

CINCINNATI, Ohio--(BUSINESS WIRE)--Camargo Pharmaceutical Services is adding expertise to its projects and helping postdoctoral researchers gain real-world experience through a unique internship program.

March 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq:BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that the first subject with...

March 27, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today issued the following statement in response to two recent lawsuits filed in the name of CytRx...

March 27, 2014

--(BUSINESS WIRE)--BioFlorida Latin America & Caribbean Life Sciences Conference will provide attendees with an opportunity to explore business collaborations and share best practices in all areas of life sciences.

March 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Initiates Phase 1/2 Trial of SAGE-547 in Status Epilepticus